Join to View Full Profile
8300 Floyd Curl Drive6th Floor -6ASan Antonio, TX 78229
Phone+1 210-450-9400
Fax+1 210-450-6024
Dr. Carter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Tufts Medical CenterResidency, Ophthalmology, 1978 - 1979- Tufts Medical Center1979
Boston University Medical CenterResidency, Neurology, 1978- Boston University Medical CenterResidency, Neurology, 1974 - 1975
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1970 - 1971- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Internal Medicine, 1969 - 1970
University of Arkansas For Medical Sciences College of MedicineClass of 1969
Certifications & Licensure
TX State Medical License 1983 - 2026
AR State Medical License 1998 - 2025
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- 17 citationsThe Effects of Hyperbaric Oxygen Therapy in Patients with Central Retinal Artery Occlusion - A Retrospective Study, Systematic Review and Meta-analysis.Luca Rosignoli, Edward R. Chu, John E. Carter, Daniel A. Johnson, Jeong-Hyeon Sohn
Korean Journal of Ophthalmology. 2021-11-08 - Lambert[FIGURE DASH]Eaton Myasthenia Syndrome Initial Presentation Mimicking Myasthenia Gravis.So Yeon Uhm, Huy V. Nguyen, Kunal P. Kanakia, John E. Carter
Journal of Neuro-Ophthalmology. 2021-08-04 - 16 citationsOptic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment TrialMichael Wall, Matthew J. Thurtell, Rudrani Banik, Sanjay Kedhar, Flora Levin
The British Journal of Ophthalmology. 2017-01-27
Other
- Anticoagulant, antiplatelet, and fibrinolytic (thrombolytic) therapy in patients at high risk for ocular hemorrhageCarter JE
http://www.uptodate.com/contents/anticoagulant-antiplatelet-and-fibrinolytic-thrombolytic-therapy-in
UpToDate, Wolters Kluwer Health - 2012-09-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
